Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the ...
Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...
Company to Participate in BIO Partnering Summit and Present Phase 1 Ketamir-2 Data at American Association for Cancer ...
Life-saving antibiotics that could treat severe infections in babies and children aren't accessible due to a lack of data ...
When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete ...
PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
In a new draft guidance issued on January 14, 2026, the FDA discussed the use of a modern statistical methodology in clinical trials designed to ...
Navigating today’s rapidly evolving clinical trial landscape can be tough. With intricate protocols and shifting regulatory demands, it’s more difficult than ever to find and keep participants, as ...
This article is part of our series on clinical data considerations. Read How to Prepare for Disclosure. For publicly traded biotech companies, disclosing clinical trial data can be an exciting ...
As a doctor working in genomic research, I know that we lack vital data for Black people and many other groups. Here's how we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results